SHORT-TERM OUTCOME OF ENDOVASCULAR INTERVENTION IN THE TREATMENT OF BELOW-KNEE ARTERY DISEASE AT CHO RAY HOSPITAL

Văn Nút Lâm1,, Thành Hưng Nguyễn1
1 Cho Ray hospital

Main Article Content

Abstract

Introduction: Peripheral Artery Disease (PAD) is caused by atherosclerotic lesions that affect the blood supply to the legs, often leading to severe chronic limb ischemia (CLI). Below-knee artery disease (BKAD) accounts for 39.4% of patients, 97% with CLI symptoms1,2. The mortality rate is high, mainly due to cardiovascular events. The treatment of BKAD with CLI presents unique challenges, but with advances in technology and techniques, endovascular interventions are reducing open surgery rates and increasing technical and clinical success rates. Objectives: To evaluate short-term outcomes of below-knee endovascular interventions at Cho Ray Hospital. Methods: A retrospective descriptive study of a case series. Results: The study of 39 cases of chronic BKAD treated with endovascular intervention at Cho Ray Hospital can draw some conclusions as follows: The clinical characteristics of chronic BKAD patients are often found in the age group of 70-79, with men accounting for 53.9%, and the main risk factors being hypertension, smoking, diabetes, and dyslipidemia. The disease stage is mostly Rutherford 5; the average ABI before intervention is 0.36. Endovascular intervention in treating chronic BKAD is a safe and effective method, with a technical success rate of 90%, a 90.3% success rate in patients with ABI < 1.4, and a complication rate of 12.8%. After one year of intervention, the clinical success rate was 84.6%, the limb salvage rate was 92.1%, and the mortality rate was 10.3%. The clinical stage before intervention affects clinical success after the intervention; precisely, the more severe the clinical stage, the lower the clinical success rate. However, the degree of artery damage, severe calcification, or the number of foot arteries that are reperfused does not affect intervention outcomes. Conclusion:  Endovascular intervention is an effective and safe treatment method for patients with chronic BKAD. However, the disease stage and other clinical factors may affect intervention outcomes. Accurately assessing these factors is crucial in selecting the appropriate treatment method and achieving the best results for the patient. 

Article Details

References

1. Clarà A, Merino J, Planas A, et al. Infrapopliteal arterial occlusive disease in elderly men: a population based study. International angiology: a journal of the International Union of Angiology. 2012;31(3):245-251.
2. Shishehbor MH, Hammad TA. Treatment of Infrapopliteal Disease in Critical Limb Ischemia. Circulation: Cardiovascular Interventions. 2016; 9(5):e003882. doi: doi:10.1161/CIRCINTERVENTIONS.116.003882
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-society consensus for the management of peripheral arterial disease (TASC II). Journal of vascular surgery. 2007;45(1):S5-S67.
4. Agarwal S, Sud K, Shishehbor MH. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003–2011. Journal of the American College of Cardiology. 2016;67(16):1901-1913.
5. Romiti M, Albers M, Brochado-Neto FC, Durazzo AES, Pereira CAB, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. Journal of vascular surgery. 2008;47(5):975-981. e1.
6. Aboyans V, Ricco J-B, Bartelink M-LE, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European heart journal. 2017;39(9):763-816.
7. Association AD. Peripheral arterial disease in people with diabetes. Diabetes care. 2003;26(12):3333-3341.
8. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arteriosclerosis, thrombosis, and vascular biology. 1998;18(2):185-192.
9. Vogelberg K, Berchtold P, Berger H, et al. Primary hyperlipoproteinemias as risk factors in peripheral artery disease documented by arteriography. Atherosclerosis. 1975;22(2):271-285.
10. Vitale E, Zuliani G, Baroni L, et al. Lipoprotein abnormalities in patients with extra-coronary arteriosclerosis. Atherosclerosis. 1990;81(2):95-102